Richard Kent, a pharmaceutical executive with experience in investigational and new drug applications, is the newest member of the board of directors at Inspire Pharmaceuticals.
He replaces Gregory Mossinghoff, the president of Inspire. His term had expired.
Inspire’s seven board members now include six independent directors.
Christy Shaffer, Inspire’s CEO, was re-elected to the board.